Evelo Biosciences Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
0.00
0
(0%)
Volume:
86
52 week range:
0.00 - 0.07
Market Cap:
8.692K
Company Description:
Evelo Biosciences, Inc. discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company also develops EDP1815, a whole-microbe candidate for the. treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19.